EGFR and non-small cell lung carcinoma: In this study, we prospectively evaluated whether PNA clamping-assisted fluorescence melting curve analysis (PANAMutyperTM) can accurately detect activating and acquired resistance EGFR mutations in plasma ctDNA derived from NSCLC patients.